Barzilai Medical Center
Ashkelon, Israel
Location contact
Daniel Leshin Carmel, MD
CONTACT
Daniel Leshin Carmel, MD
PRINCIPAL_INVESTIGATOR
Pnina Nir
CONTACT
NCT Number: NCT07767019
Investigators assume that global climate changes can influence upper respiratory tract infection peak prevalence, which may have significant clinical implication, for example, by adjusting seasonal Influenzas' vaccine timing. Therefore, the investigators will collect data from electronic medical database about patients tested positive for winter seasonal respiratory tract viruses from 2022 and compare the incidence to the meteorological profile of that season.
Trial opening soon.
Get NotifiedAll sexes
Observational
Ashkelon, Israel
Daniel Leshin Carmel, MD
CONTACT
Daniel Leshin Carmel, MD
PRINCIPAL_INVESTIGATOR
Pnina Nir
CONTACT
The seasonal cycle of respiratory viral diseases has been widely recognized for thousands of years, as annual epidemics of the common cold and influenza hit the human population like clockwork in temperate regions during winter. Many explanations for this phenomenon appear in the literature. Huang et al. reported in 2017 a decrease in Influenza incidence while average temperatures increased in Queensland, Australia. Weather variability appears to be more influential on seasonal influenza transmission among younger age groups (0-14). Not only is the temperature relevant, but all meteorological parameters also vary. For example, Qi et al. found that both low and high absolute humidity might increase influenza risk in China, and the relationship varies geographically.
The meteorological service in Israel reports a marked increase in temperature when comparing 2006-2020 to 1964-1979 and 1995-2009 across all seasons. The average warming rate from 1964-1979 to 2006-2020 is approximately 1.5°C, highlighting a notable temperature difference.
The investigators assume that global climate changes can influence Influenza peak prevalence, which may have significant clinical implication by adjusting seasonal Influenzas' vaccine timing.
The study will include identification of all patients who tested positive for URT infection with seasonal virus (Influenza, RSV, Rhinovirus, Human MetaPneumoVirus, ParaInflunza) via respiratory PCR since 2022, whether in the emergency department or during hospitalization. This will be followed by a review of medical records to extract baseline data: age, sex, weight, underlying medical conditions, and the need for hospitalization, intensive care admission, mechanical ventilation, vasopressors, or renal replacement therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention, observational retrospective study.
Time frame: 4 winter seasons, from 2022 to 2026.
Examining the incidence of severe upper respiratory tract illness (requiring hospital visits) in relation to weather changes over the last four seasons.
Time frame: 4 winter seasons, 2022 to 2026.
Analysis of winter morbidity trends among patients presenting to the hospital with Influenza. Including severity of illness (need for ICU admission, mechanical ventilation and/or inotropes assistance).
Time frame: 4 winter seasons 2022-2026
Analysis of winter mortality trends among patients presenting to the hospital with Influenza. Including mortality during hospitalization or within 30 days.
Time frame: 4 winter seasons, 2022-2026
Analysis of upper respiratory tract infection recurrence trends among patients presenting to the hospital with Influenza. Including recurrent admission within 30 days.
Contact information is provided by the study sponsor or research team.
Daniel leshin Carmel Head of Infection Control and Prevention, MD
CONTACT
Pnina Nir Study Coordinator
CONTACT
Barzilai Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07267689
Cold Symptom, Common Cold
Kielce, Poland
View Trial DetailsNCT07284914
Infections, Respiratory Tract Diseases
Legon, Ghana
View Trial DetailsNCT06907355
Cough, Infections
Santiago, Chile
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial Details